Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESPB vs IV Lidocaine in Pediatric Spinal Surgery
NCT06965933Phase 4Active, not recruiting
- Sponsor
- Saint Petersburg State University
- Start
- May 2025
- Primary completion
- Apr 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection and Lidocaine Hydrochloride Injection, without epinephrine in pain (2 arms), sponsored by Saint Petersburg State University. Primary endpoint: Time before emergency pain relief (opioid) at 24 hours. Started May 2025; status: active, not recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionLidocaine Hydrochloride Injection, without epinephrine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06965933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06965933.